WallStreetZenWallStreetZen

NASDAQ: RCM
R1 Rcm Inc Stock

$14.20-0.01 (-0.07%)
Updated Oct 14, 2024
RCM Price
$14.20
Fair Value Price
$10.04
Market Cap
$5.99B
52 Week Low
$8.87
52 Week High
$15.12
P/E
-157.78x
P/B
2.13x
P/S
3.02x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.75B
Earnings
-$40.00M
Gross Margin
-8.1%
Operating Margin
7.27%
Profit Margin
-2.3%
Debt to Equity
1.05
Operating Cash Flow
$312M
Beta
1.08
Next Earnings
Nov 2, 2024
Ex-Dividend
N/A
Next Dividend
N/A

RCM Overview

R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company also provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. The company was founded in 2003 and is headquartered in Murray, Utah.

Zen Score

Industry Average (24)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how RCM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

RCM ($14.20) is overvalued by 41.4% relative to our estimate of its Fair Value price of $10.04 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
RCM ($14.20) is not significantly undervalued (41.4%) relative to our estimate of its Fair Value price of $10.04 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
RCM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more RCM due diligence checks available for Premium users.

Be the first to know about important RCM news, forecast changes, insider trades & much more!

RCM News

Valuation

RCM fair value

Fair Value of RCM stock based on Discounted Cash Flow (DCF)
Price
$14.20
Fair Value
$10.04
Overvalued by
41.40%
RCM ($14.20) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
RCM ($14.20) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
RCM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

RCM price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-157.78x
Industry
17.55x
Market
27.44x

RCM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.13x
Industry
3.55x
RCM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

RCM's financial health

Profit margin

Revenue
$0.0
Net Income
-$7.6M
Profit Margin
0%
RCM's Earnings (EBIT) of $127.40M... subscribe to Premium to read more.
Interest Coverage Financials
RCM's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$5.8B
Liabilities
$3.0B
Debt to equity
1.05
RCM's short-term assets ($755.70M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RCM's long-term liabilities ($2.55B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RCM's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
RCM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$36.8M
Investing
-$26.4M
Financing
-$24.9M
RCM's operating cash flow ($311.50M)... subscribe to Premium to read more.
Debt Coverage Financials

RCM vs Health Information Service Stocks

TickerMarket Cap1d %P/EP/B
RCM$5.99B-0.07%-157.78x2.13x
WAY$4.62B-0.50%-48.84x1.57x
HQY$7.42B-0.53%69.65x3.44x
DOCS$7.79B-3.12%48.79x8.53x
EVH$3.15B+0.26%-28.56x2.99x

R1 Rcm Stock FAQ

What is R1 Rcm's quote symbol?

(NASDAQ: RCM) R1 Rcm trades on the NASDAQ under the ticker symbol RCM. R1 Rcm stock quotes can also be displayed as NASDAQ: RCM.

If you're new to stock investing, here's how to buy R1 Rcm stock.

What is the 52 week high and low for R1 Rcm (NASDAQ: RCM)?

(NASDAQ: RCM) R1 Rcm's 52-week high was $15.12, and its 52-week low was $8.87. It is currently -6.08% from its 52-week high and 60.09% from its 52-week low.

How much is R1 Rcm stock worth today?

(NASDAQ: RCM) R1 Rcm currently has 422,108,963 outstanding shares. With R1 Rcm stock trading at $14.20 per share, the total value of R1 Rcm stock (market capitalization) is $5.99B.

R1 Rcm stock was originally listed at a price of $2.70 in Mar 15, 2017. If you had invested in R1 Rcm stock at $2.70, your return over the last 7 years would have been 425.93%, for an annualized return of 26.76% (not including any dividends or dividend reinvestments).

How much is R1 Rcm's stock price per share?

(NASDAQ: RCM) R1 Rcm stock price per share is $14.20 today (as of Oct 14, 2024).

What is R1 Rcm's Market Cap?

(NASDAQ: RCM) R1 Rcm's market cap is $5.99B, as of Oct 15, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

R1 Rcm's market cap is calculated by multiplying RCM's current stock price of $14.20 by RCM's total outstanding shares of 422,108,963.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.